Literature DB >> 10605940

Effects of nerve growth factor and nicotine on the expression of nicotinic acetylcholine receptor subunits in PC12 cells.

T Takahashi1, H Yamashita, S Nakamura, H Ishiguro, T Nagatsu, H Kawakami.   

Abstract

The neuroprotective effect of nicotine via nicotinic acetylcholine receptor (nAChR) has been reported in differentiated PC12 cells. We examined the effects of nerve growth factor (NGF) and nicotine on the expressions of the nAChR subunits alpha3, alpha5, alpha7, beta2, beta3 and beta4, in PC12 cells using Northern blot analysis. NGF increased the transcriptions of alpha5 (1,4- to 2,3-fold), alpha7 (1.7- to 2.5-fold) and beta4 (1.9- to 3.0-fold) subunits, but changes in alpha3 and beta2 subunit levels were smaller than alpha5, alpha7, or beta4. Nicotine also increased the levels of mRNA encoding alpha5 and beta2 subunits. The pattern of subunit mRNA changes was different between NGF and nicotine treatment. No signal for beta3 subunit was detected. The results suggest that NGF changes the expression of nAChR in a subtype-specific manner over the course of the differentiation, and the disproportionate subunit expressions might be related to the neuroprotective effect exerted by nicotine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10605940     DOI: 10.1016/s0168-0102(99)00064-4

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  2 in total

1.  Redistribution of adrenomedullary nicotinic acetylcholine receptor subunits and the effect on circulating epinephrine levels in a murine model of acute asthma.

Authors:  Xi Chen; Juntao Feng; Chengping Hu; Qingwu Qin; Yuanyuan Li; Ling Qin
Journal:  Int J Mol Med       Date:  2016-12-23       Impact factor: 4.101

2.  Gymnodimine A and 13-desMethyl Spirolide C Alter Intracellular Calcium Levels via Acetylcholine Receptors.

Authors:  Joyce A Nieva; Bernd Krock; Urban Tillmann; Jan Tebben; Christian Zurhelle; Ulf Bickmeyer
Journal:  Toxins (Basel)       Date:  2020-11-27       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.